Back
Nektar Therapeutics Vs. Cara Therapeutics Industry Stock Comparison
Sell
42
NKTR
Nektar Therapeutics
Last Price:
1.76
Seasonality Move:
-3.09%
Sell
39
CARA
Cara Therapeutics
Last Price:
0.75
Seasonality Move:
20.6%
Sell
42
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
- The current Nektar Therapeutics [NKTR] share price is $1.76. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Cara Therapeutics (CARA)
is a Sell
Is Cara Therapeutics a Buy, Sell or Hold?
- The current Cara Therapeutics [CARA] share price is $0.75. The Score for CARA is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- CARA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $1.76
The current trend is moderately bullish and NKTR is experiencing slight selling pressure.
CARA Stock Price Chart
What is Cara Therapeutics's stock price today?
-
The Cara Therapeutics share price today is $0.75
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CARA is experiencing selling pressure, which indicates risk of future bearish movement.
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.14 | Buy |
| Relative Strength Index (14 RSI): | 61.96 | Buy |
| Chaikin Money Flow: | -180239 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.38 - 1.72) | Buy |
| Bollinger Bands (100): | (0.55 - 1.37) | Buy |
CARA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 48.71 | Sell |
| Chaikin Money Flow: | -250869 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.7 - 0.78) | Buy |
| Bollinger Bands (100): | (0.61 - 0.87) | Buy |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.74 | Buy |
| 20-day SMA: | 1.58 | Buy |
| 50-day SMA: | 1.29 | Buy |
| 200-day SMA: | 0.77 | Buy |
| 8-day EMA: | 1.73 | Buy |
| 20-day EMA: | 1.61 | Buy |
| 50-day EMA: | 1.35 | Buy |
| 200-day EMA: | 1.07 | Buy |
CARA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.75 | Buy |
| 20-day SMA: | 0.74 | Buy |
| 50-day SMA: | 0.8 | Sell |
| 200-day SMA: | 1.22 | Sell |
| 8-day EMA: | 0.76 | Sell |
| 20-day EMA: | 0.76 | Sell |
| 50-day EMA: | 0.78 | Sell |
| 200-day EMA: | 1.67 | Sell |
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and an increase next year of $0.21 per share.
Cara Therapeutics Earnings Growth & CARA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.67 per share, and an increase next year of $0.48 per share.
Nektar Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cara Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||